Serial Number | 90481362 |
Word Mark | T T-DETECT |
Filing Date | Friday, January 22, 2021 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, September 11, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, December 13, 2022 |
Description of Mark | The mark consists of a capitalized letter "T" in stylized form, underneath which is the word "T-Detect". |
Goods and Services | Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection |
Goods and Services | Medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services related to the treatment of persons; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing. |
Goods and Services | Development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immunedisorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 23, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 3, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 3, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Adaptive Biotechnologies Corp. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98102 |
Party Name | Adaptive Biotechnologies Corp. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98102 |
Event Date | Event Description |
Monday, September 11, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, September 11, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, February 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, December 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, December 13, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, November 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, November 7, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, November 3, 2022 | EXAMINER'S AMENDMENT ENTERED |
Thursday, November 3, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, November 3, 2022 | EXAMINERS AMENDMENT E-MAILED |
Thursday, November 3, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Monday, April 11, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, April 11, 2022 | NON-FINAL ACTION E-MAILED |
Monday, April 11, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, April 5, 2022 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, March 8, 2022 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Thursday, February 24, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, February 1, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, January 31, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 31, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, July 30, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, July 30, 2021 | NON-FINAL ACTION E-MAILED |
Friday, July 30, 2021 | NON-FINAL ACTION WRITTEN |
Tuesday, July 20, 2021 | ASSIGNED TO EXAMINER |
Friday, April 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 26, 2021 | NEW APPLICATION ENTERED |